Existing Account?

Copyrights © 2010-2026 MBI Symposium All Right Reserved.

For general enquiries, please contact Ms. Wendy Fang
+886-2-27988329 Ext. 58 2026mbisymposium@gmail.com

Scientific Programme

The symposium will feature a diverse scientific program, including plenary keynotes, symposia, oral presentations, and 5-minute poster blitz presentations, bringing together leading scientists and experts from around the world. The symposium will be held at Conference Hall, B2 floor, Excellence Building at China Medical University (Shuinan Campus), Taichung, Taiwan.

Programme Overview

 

 

Programme Details

PK1. Plenary Keynote 1

Vita Lanfranchi, Ph.D., United Kingdom | From Lab to Life: Leveraging IMUs and Smartphones to Predict Disease Progression through Digital Mobility Outcomes.

PK2. Plenary Keynote 2

Kuan-Pin Su, Ph.D., Taiwan | Mind-Body Interventions and Psychoneuroimmune Modulation in Depression in the Digital Era

PK3. Plenary Keynote 3

Andre Sourander, MD, Ph.D., Finland

PK4. Plenary Keynote 4

Christoph U. Correll, MD, United States | Harnessing Artificial Intelligence to Improve Clinical Outcomes in Mental Health: The Role of Large Language Models and Clinician Decision Support Systems

S11. Decoding the Metabolism–Brain–Sleep Axis

  • Tae Kim, M.D., Ph.D. (Chair) | REM Sleep Suppression During Diazoxide-Induced Acute Hyperglycemia in a Non-Diabetic Mouse Model
  • Insung Park, Ph.D. | Metabolic Inflexibility During Sleep: Insights From Whole-Room Indirect Calorimetry
  • Jae Gwan Kim, Ph.D. | Engineered Prefrontal fNIRS Functional Connectivity Features for Asymptomatic Alzheimer's Disease Detection
  • Dongsung Lee, Ph.D. | Epigenomic and Chromosomal Architectural Reconfiguration in Developing Human Frontal Cortex and Hippocampus

S12. Advances in Brain Modulation

  • Jia-Jin Chen, Ph.D. (Chair)
  • Chien-An Chen, PhD Candidate | Closed-Loop Neuromodulation Using fNIRS-Guided HD-tES: Opportunities and Future Directions
  • Che-Wei Lin, Ph.D. | Connectivity-Aware Deep Learning on Wearable fNIRS: Subject-Independent Anxiety Assessment and Its Path to Closed-Loop Neuromodulation
  • Hsieh, Tsung-Hsun, Ph.D. | Neuromodulation Strategies in Neurorehabilitation: From Mechanistic Insights to Precision Neurotherapy
  • Yi-Jing Huang, Ph.D. | Neurophysiological profiling and high-definition transcranial electrical stimulation treatment for generalized anxiety disorder

S21. Gut–Brain Axis & Psychobiotics in Psychiatry

  • Jane Pei-Chen Chang, MD, Ph.D. (Chair)
  • Quang Le Do, MD | Omega-3 Reshape Gut Microbiota in Depression and ADHD
  • Enchia Tsai, Msc | Clinical Translation and Therapeutic Impact of Psychobiotic L. plantarum PS128 on Neurodevelopmental Health
  • Wei-Hsiang Lin, Ph.D. | Translational Evidence of the Gerobiotic Lacticaseibacillus paracasei PS23 in Subjective Cognitive Decline: From Mechanistic Models to Human Outcomes
  • Liang-Jen Wang, MD, MPH, Ph.D. | Interaction of Candida albicans with bacteria and pathogenesis mechanism in attention-deficit/hyperactivity disorder

S22. Nutritional Psychiatry: Clinical Insights from Japan

  • Ryohei Takeno, MD (Co-Chair)
  • Shizuka Ota, MD (Co-Chair)
  • Tomoyuki Okudaira, MD | Development of Nutritional Psychiatry in Japan: From Clinical Experience to Academic Society Formation
  • Yohei Kita, MD, PhD | Suspected Thiamine Deficiency in Malnourished Psychiatric Inpatients: Early Recognition and Empirical Nutritional Intervention
  • Hiroyuki Konno, MD, PhD | Cognitive Improvement in an 83-Year-Old Male With Mild Cognitive Impairment After Multimodal Nutritional and Metabolic Intervention Including Exogenous Ketone Supplementation: A Case Report

S23. Rewiring the Inflamed Mind: Immuno-Psychiatry

  • Piotr Gałecki, M.D, Ph.D. (Co-Chair) | From Inflammatory Depression to Personalized Immunopsychiatry: Clinical Standards and Translational Pathways
  • Marta Broniarczyk-Czarniak, M.D, Ph.D. (Co-Chair) | Neuropeptides, Social Stress, and the Immune-Brain Interface in Severe Mental Disorders
  • Gracja Ryznar, M.D. | Cytokines and the Mind: Immunological Underpinnings of Depression and Anxiety Symptoms
  • Katarzyna Bliźniewska-Kowalska, M.D., Ph.D. | Breaking the Brain’s Resilience: How Inflammatory Pathways Impair Neuroplasticity
  • Małgorzata Gałecka, Psych., Ph.D. | Healing Beyond the Mind: The Impact of Psychotherapy on the Immunological Profile

S24. AI in Psychiatry: From Research to Clinic

  • Taishiro Kishimoto, MD, Ph.D. (Chair) | Artificial Intelligence in Society and Psychiatric Care: A Narrative Review of Opportunities and Challenges
  • Kuo-ching Liang, Ph.D. | Wearable-Derived Physiological Markers for Depression Screening and Severity Estimation
  • Hironobu Nakamura, M.D., Ph.D. | Language as a Clinical Interface: NLP-Based Assessment, Illness Monitoring, and Responsible AI in Schizophrenia

Special Lecture (中文演講) 

Samuel Shun-Min Wang (王舜民), Ph.D. | 智慧醫療軟體（SaMD）與 AI/ML 醫材的全球法規策略 (Global Regulatory Strategies for SaMD and AI/ML Medical Devices)

Chun-Hui Liao (廖俊惠)

5-min Poster Blitz

  • Wen-Chin Yu
  • Jianjung Ying
  • Aimal Khan
  • Sanae Hasegawa-Ishii
  • Szu Han Chen